Sciclone Pharmaceut (SCLN)
11.15 unch (unch) 10/13/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Oct 13th, 2017
Results
download Want to compare other data? Select Fields| Symbol | SCLN | ORGO | AKBA | ||
| Company | Sciclone Pharmaceut | Organogenesis Holdings Inc | Akebia Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.15 | 4.89 | 2.36 | ||
| High | 11.20 | 4.93 | 2.45 | ||
| Low | 11.15 | 4.66 | 2.34 | ||
| Last | 11.15 | 4.91 | 2.41 | ||
| Change | unch | +0.03 | -0.02 | ||
| % Change | unch | +0.61% | -0.82% | ||
| Volume | 2,224,600 | 1,664,400 | 3,578,500 | ||
| 20-Day Average Volume | 493,170 | 1,560,190 | 4,002,810 | ||
| Previous Close | 11.15 | 4.88 | 2.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.13 | 4.28 | 2.00 | ||
| 20-Day Raw Stochastic | 66.67% | 98.93% | 92.71% | ||
| 20-Day Relative Strength | 55.03% | 57.97% | 62.29% | ||
| Weighted Alpha | +13.70 | +12.74 | +54.15 | ||
| Today's Opinion | N/A | 80% Buy | 72% Buy | ||
| Previous Opinion | N/A | 80% Buy | 56% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 10/06/17 | +10.34% since 04/23/25 | +11.57% since 04/23/25 | ||
| Low | 11.05 on 10/10/17 | 4.20 on 04/25/25 | 2.15 on 04/24/25 | ||
| High | 11.20 on 10/13/17 | 4.93 on 04/30/25 | 2.48 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +0.45% since 09/13/17 | +9.11% since 03/28/25 | +26.18% since 03/28/25 | ||
| Low | 11.02 on 09/15/17 | 3.52 on 04/07/25 | 1.52 on 04/10/25 | ||
| High | 11.20 on 10/13/17 | 4.93 on 04/30/25 | 2.48 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | +2.06% since 07/13/17 | +30.24% since 01/30/25 | +4.78% since 01/30/25 | ||
| Low | 10.90 on 08/02/17 | 3.07 on 02/27/25 | 1.52 on 04/10/25 | ||
| High | 11.43 on 08/03/17 | 6.71 on 03/03/25 | 2.89 on 03/19/25 | ||
| 6-Month | |||||
| %Chg | +16.15% since 04/13/17 | +69.90% since 10/30/24 | +41.76% since 10/30/24 | ||
| Low | 9.18 on 05/26/17 | 2.75 on 11/04/24 | 1.52 on 04/10/25 | ||
| High | 11.43 on 08/03/17 | 6.71 on 03/03/25 | 2.89 on 03/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 581,918 | 618,921 | 574,041 | ||
| Shares Outstanding, K | 52,190 | 126,828 | 236,231 | ||
| Annual Sales | 160,100,000 | 482,040,000 | 160,180,000 | ||
| Annual Net Income | 30,730,000 | 860,000 | -69,410,000 | ||
| Last Quarter Sales | 44,520,000 | 126,660,000 | 46,500,000 | ||
| Last Quarter Net Income | 12,190,000 | 7,670,000 | -22,800,000 | ||
| 60-Month Beta | 1.72 | 1.79 | 0.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.04 on 02/27/25 | -0.10 on 03/13/25 | ||
| Latest Earnings Date | 11/08/17 | 05/08/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 12.25 | 0.00 | 0.00 | ||